Financial Reports Latest Updates Industry Maps Economic Calendar

ANAVEX LIFE SCIENCES CORP. (AVXL) Annual Reports

Q: Where can I read ANAVEX LIFE SCIENCES CORP. (AVXL) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

ANAVEX LIFE SCIENCES CORP. is listed on Nasdaq, classified by the SEC under Biological Products, (No Diagnostic Substances) (SIC 2836). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 09/30
SEC CIK： 1314052 →

Website：Official site ↗

Financial Highlights

FY2026 Q3 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Operating income	$6.7M	$-14.5M	+146.6%
Net income	$7.8M	$-13.2M	+159.1%
EPS (diluted)	$0.08	$-0.16	+150.0%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Net income 7.82 mn

Periods follow the company’s fiscal year (Apple ends in September, Walmart in January), so they differ from calendar quarters.

Show table：Income statement

Item	2009Q4	2010Q3	2010Q4	2011Q2	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2	2026Q3
Operating income	—	-1.30	-1.96	-1.37	-1.95	-1.64	-1.23	-2.19	-0.8	-0.7	-0.64	-0.42	-0.13	-0.13	-1.47	-0.31	-1.02	-1.00	-0.64	-0.77	-0.86	-1.51	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-31.1	—	—	—	-42.0	-11.7	-11.5	-12.5	-15.3	-15.4	-14.2	-13.5	-12.7	-11.3	-12.5	-14.7	-14.3	-13.6	-12.5	-14.5	-10.8	-6.78	-6.48	6.74
Net income	-5.50	-1.97	-2.79	-1.89	-1.97	-1.58	-1.42	-2.17	-0.91	-4.54	-0.68	-0.45	-0.11	-0.15	-2.99	0.36	-1.02	-1.01	-9.70	-0.79	-1.72	-4.24	-5.36	-3.95	-2.03	-2.24	-6.51	-3.15	-1.55	-3.61	-5.15	-4.06	-4.75	-2.85	-5.79	-7.33	-8.01	-7.07	-3.88	-6.59	-7.24	-6.49	-5.97	-7.86	-8.16	-10.2	-11.7	-10.9	-10.4	-12.4	-14.3	-13.0	-13.1	-11.3	-10.2	-8.62	-10.6	-12.2	-11.6	-12.1	-11.2	-13.2	-9.83	-5.68	-5.34	7.82

Balance sheet

Quarterly · In mn (USD)

Total assets 120 mn Total liabilities 7.69 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q3	2010Q4	2011Q2	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2	2026Q3
Current assets	—	—	0.33	—	—	1.28	0.2	0.08	0.19	0.02	0.01	0.08	0	0	0.39	0.15	9.22	8.20	7.35	7.05	6.36	7.98	15.5	14.0	12.1	9.84	9.45	21.3	23.6	24.9	27.8	28.3	25.8	26.7	24.3	22.1	20.6	21.8	25.3	—	—	31.6	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	—	—	0.33	—	—	1.28	0.2	0.08	0.19	0.02	0.01	0.08	0	0	0.39	0.15	10.3	9.31	7.35	7.05	6.36	7.98	15.5	14.0	12.1	9.84	9.50	21.4	23.6	24.9	27.8	28.3	25.9	26.8	24.4	22.1	20.6	22.0	25.3	31.4	31.0	31.6	34.5	54.3	83.6	166	162	157	160	160	153	148	159	158	154	148	145	142	136	124	117	102	104	133	129	120
Current liabilities	—	—	—	—	—	—	—	—	—	—	2.89	—	—	—	1.95	1.82	1.88	1.90	1.44	1.42	1.53	1.35	2.66	2.53	2.43	2.17	3.19	2.19	2.12	1.45	3.58	2.80	3.42	3.21	3.88	4.88	6.37	4.34	5.04	5.46	6.23	6.95	7.31	8.03	7.76	—	10.8	10.5	8.07	9.48	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total liabilities	—	—	3.29	—	—	2.25	1.35	2.57	3.12	2.22	2.89	3.41	3.44	3.56	2.86	1.82	1.88	1.91	7.16	6.58	1.66	1.41	2.66	2.53	2.43	2.17	3.19	—	—	—	3.58	—	—	—	—	—	—	—	5.04	—	—	—	7.31	—	—	9.27	10.8	—	—	—	10.2	13.3	14.0	11.1	12.5	12.5	9.56	11.8	15.3	13.1	17.4	11.5	8.95	6.37	7.06	7.69
Equity	-3.86	—	-2.96	—	—	-0.97	-1.14	-2.48	-2.93	-2.20	-2.88	-3.33	-3.43	-3.55	-2.46	-1.67	8.41	7.41	0.19	0.47	4.70	6.57	12.8	11.5	9.68	7.67	6.31	19.2	21.5	23.4	24.3	25.6	22.5	23.6	20.5	17.2	14.2	17.6	20.3	26.0	24.8	24.7	27.2	46.3	75.8	157	151	146	152	151	142	135	145	147	142	136	135	130	120	111	99.8	91.0	94.9	127	122	112

Cash flow

Quarterly · In mn (USD)

Operating -9.10 mn Investing 0 mn Financing 0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q3	2010Q4	2011Q2	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2	2026Q3
Operating	—	-2.93	-1.66	-1.08	-0.59	-13.2	-0.92	-1.09	-0.11	-0.24	-0.25	-0.13	-0.13	-0.03	-0.48	-0.43	-0.35	-0.96	-0.92	-0.69	-0.67	-1.43	-1.43	-3.25	-1.90	-2.22	-1.86	-3.15	-0.7	-2.97	-2.19	-3.62	-2.82	-2.09	-4.05	-4.16	-4.33	-7.50	-2.53	-5.73	-5.26	-4.04	-6.25	-7.87	-7.32	-7.52	-7.67	-3.50	-9.64	-7.05	-4.04	-5.79	-8.49	-7.65	-5.85	-7.32	-11.7	-5.18	-6.66	-12.1	-5.86	-12.5	-8.60	-7.15	-4.44	-9.10
Investing	—	—	0	0	0	-0.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Financing	—	4.04	0.47	1.24	0.17	14.4	-0.17	0.96	0.28	0.08	0.25	0.2	0.05	0.03	0.83	0.19	9.45	-0.05	0	0.41	0	3.08	8.76	1.81	0	0	1.32	15.1	2.89	4.42	4.84	4.23	0.43	2.26	1.16	1.94	3.07	9.29	3.47	11.0	4.37	5.10	7.88	26.0	35.8	89.2	2.22	2.54	11.8	6.91	0	0.26	18.3	9.00	2.06	0.06	7.28	4.55	0.09	0.71	0.85	-2.14	10.0	36.3	0.11	0
Cash at period end	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	9.19	—	23.4	24.8	27.4	28.1	25.7	25.8	22.9	20.7	19.5	21.3	22.2	27.5	26.6	27.6	29.3	47.4	75.9	158	152	151	153	153	149	144	153	155	151	144	139	139	132	121	116	101	103	132	127	118

Returns & leverage

Quarterly · %

ROE -12.8% ROA -11.7% Debt ratio 6.4%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q3	2010Q4	2011Q2	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2	2026Q3
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-152.8%	-241.6%	—	—	-201.7%	-235.4%	-186.3%	-255.4%	-216.6%	-190.8%	-154.2%	-90.8%	-86.3%	-95.2%	-88.1%	-64.3%	-80.0%	-71.5%	-78.0%	-96.9%	-130.8%	-136.9%	-129.0%	-118.4%	-127.2%	-114.4%	-110.6%	-76.2%	-56.6%	-35.4%	-42.6%	-42.5%	-37.9%	-29.5%	-32.7%	-35.6%	-35.5%	-34.7%	-33.4%	-31.9%	-29.0%	-30.0%	-32.8%	-37.7%	-40.2%	-43.6%	-43.1%	-33.6%	-30.8%	-12.8%
ROA	—	—	—	—	—	-643.3%	-2574.4%	-8449.0%	-3184.2%	-1390.7%	-7682.9%	-8004.9%	-6033.4%	-10844.6%	-1820.0%	-2502.7%	-73.8%	-100.0%	-293.5%	-347.5%	-158.7%	-190.3%	-106.1%	-145.0%	-168.6%	-152.4%	-118.0%	-78.7%	-75.3%	-85.3%	-72.1%	-57.8%	-71.0%	-65.0%	-66.8%	-82.2%	-103.3%	-115.7%	-105.8%	-95.5%	-96.1%	-90.3%	-87.8%	-64.2%	-49.7%	-32.5%	-38.6%	-38.8%	-35.5%	-27.8%	-30.5%	-32.8%	-33.0%	-32.5%	-30.9%	-29.1%	-26.7%	-27.8%	-29.7%	-34.2%	-36.0%	-39.5%	-38.8%	-31.1%	-27.7%	-11.7%
Debt ratio	—	—	997.5%	—	—	176.1%	662.6%	3033.2%	1632.4%	10029.0%	21959.4%	4266.1%	705395.3%	102208.2%	726.1%	1207.0%	18.3%	20.5%	97.4%	93.3%	26.1%	17.7%	17.2%	18.1%	20.1%	22.1%	33.6%	—	—	—	12.9%	—	—	—	—	—	—	—	19.9%	—	—	—	21.1%	—	—	5.6%	6.7%	—	—	—	6.7%	8.9%	8.8%	7.0%	8.1%	8.4%	6.6%	8.3%	11.3%	10.6%	14.8%	11.2%	8.6%	4.8%	5.5%	6.4%

EPS

Quarterly · US$

EPS US$0.08

Show table：EPS

Item	2009Q4	2010Q3	2010Q4	2011Q2	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q4	2012Q4	2012Q4	2013Q4	2013Q4	2013Q4	2013Q4	2014Q4	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2	2026Q3
EPS（US$）	—	-0.09	-0.13	-0.08	-0.08	-0.06	-0.05	-0.08	-0.03	-0.16	-0.01	-0.01	0.00	-0.01	-0.10	-0.01	-0.03	-0.03	-0.24	-0.02	-0.03	-0.06	-0.54	-0.12	-0.06	-0.06	-0.18	-0.08	-0.04	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.54	—	—	—	-0.62	-0.17	-0.17	-0.14	-0.13	-0.11	-0.13	-0.14	-0.14	-0.14	-0.13	-0.16	-0.11	-0.06	-0.06	0.08

Revenue & profit

Year-to-date · In mn (USD)

Net income -3.19 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 120 mn Total liabilities 7.69 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -20.7 mn Investing 0 mn Financing 36.4 mn

Positive = cash in, negative = cash out.

Returns & leverage

Year-to-date · %

ROE -12.8% ROA -11.7% Debt ratio 6.4%

EPS

Year-to-date · US$

EPS US$-0.04

Revenue & profit

Annual · In mn (USD)

Net income -46.4 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating income	—	—	—	—	—	—	—	-51.0	-55.8	-52.9	-51.4
Net income	-12.1	-14.7	-13.5	-17.4	-26.3	-26.3	-37.9	-48.0	-47.5	-43.0	-46.4

Balance sheet

Annual · In mn (USD)

Total assets 104 mn Total liabilities 8.95 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	15.5	9.45	27.8	24.3	25.3	—	—	—	—	—	—
Total assets	15.5	9.50	27.8	24.4	25.3	34.5	162	153	154	136	104
Current liabilities	2.66	3.19	3.58	3.88	5.04	7.31	10.8	—	—	—	—
Total liabilities	2.66	3.19	3.58	—	5.04	7.31	10.8	10.2	12.5	15.3	8.95
Equity	12.8	6.31	24.3	20.5	20.3	27.2	151	142	142	120	94.9

Cash flow

Annual · In mn (USD)

Operating -39.0 mn Financing 9.43 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-4.23	-9.24	-9.02	-12.6	-18.5	-21.3	-30.4	-24.2	-27.8	-30.8	-39.0
Financing	12.3	3.13	27.3	8.07	17.8	28.4	153	21.3	29.6	12.0	9.43
Cash at period end	—	9.19	27.4	22.9	22.2	29.3	152	149	151	132	103

Returns & leverage

Annual · %

ROE -43.1% ROA -38.8% Debt ratio 8.6%

Show table：Returns & leverage

Item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-94.5%	-154.2%	-88.1%	-78.0%	-129.0%	-110.6%	-42.6%	-32.7%	-33.4%	-32.8%	-43.1%
ROA	-78.3%	-118.0%	-72.1%	-66.8%	-105.8%	-87.8%	-38.6%	-30.5%	-30.9%	-29.7%	-38.8%
Debt ratio	17.2%	33.6%	12.9%	—	19.9%	21.1%	6.7%	6.7%	8.1%	11.3%	8.6%

EPS

Annual · US$

EPS US$-0.54

Show table：EPS

Item	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	-0.65	-0.42	—	—	—	—	—	—	-0.61	-0.52	-0.54

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read ANAVEX LIFE SCIENCES CORP. (AVXL) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.